CD274 and melanoma: The subgroup of Ciita+ B16 melanoma cells with the highest degree of MHC-II positivity (30%) at the time of injection, treated with anti-PD-L1, had slower tumour formation and prolonged survival, although the effect was marginal (Supplementary Fig. 9B).